Update in oncology

Julie R. Brahmer

doi:10.7326/0003-4819-143-8-200510180-00009

Update in oncology

Julie R. Brahmer

School of Medicine

Research output: Contribution to journal › Review article › peer-review

Abstract

This Update in Oncology focuses on new treatments for 4 common tumors in patients: prostate cancer, non-small-cell lung cancer, breast cancer, and colorectal cancer. The hot topics in 2004 were docetaxel for prostate cancer and pemetrexed and epidermal growth factor receptor mutations for non-small-cell lung cancer. The major advance for breast cancer was the use of aromatase inhibitors for adjuvant treatment. For colorectal cancer, the major development was the outcome of the trials studying bevacizumab and cetuximab.

Original language	English (US)
Pages (from-to)	587-592
Number of pages	6
Journal	Annals of internal medicine
Volume	143
Issue number	8
DOIs	https://doi.org/10.7326/0003-4819-143-8-200510180-00009
State	Published - Oct 18 2005

ASJC Scopus subject areas

Internal Medicine

Access to Document

10.7326/0003-4819-143-8-200510180-00009

Cite this

@article{6e03834c8ae748a7bd5541e3ac549240,

title = "Update in oncology",

abstract = "This Update in Oncology focuses on new treatments for 4 common tumors in patients: prostate cancer, non-small-cell lung cancer, breast cancer, and colorectal cancer. The hot topics in 2004 were docetaxel for prostate cancer and pemetrexed and epidermal growth factor receptor mutations for non-small-cell lung cancer. The major advance for breast cancer was the use of aromatase inhibitors for adjuvant treatment. For colorectal cancer, the major development was the outcome of the trials studying bevacizumab and cetuximab.",

author = "Brahmer, {Julie R.}",

year = "2005",

month = oct,

day = "18",

doi = "10.7326/0003-4819-143-8-200510180-00009",

language = "English (US)",

volume = "143",

pages = "587--592",

journal = "Annals of internal medicine",

issn = "0003-4819",

publisher = "American College of Physicians",

number = "8",

}

TY - JOUR

T1 - Update in oncology

AU - Brahmer, Julie R.

PY - 2005/10/18

Y1 - 2005/10/18

N2 - This Update in Oncology focuses on new treatments for 4 common tumors in patients: prostate cancer, non-small-cell lung cancer, breast cancer, and colorectal cancer. The hot topics in 2004 were docetaxel for prostate cancer and pemetrexed and epidermal growth factor receptor mutations for non-small-cell lung cancer. The major advance for breast cancer was the use of aromatase inhibitors for adjuvant treatment. For colorectal cancer, the major development was the outcome of the trials studying bevacizumab and cetuximab.

AB - This Update in Oncology focuses on new treatments for 4 common tumors in patients: prostate cancer, non-small-cell lung cancer, breast cancer, and colorectal cancer. The hot topics in 2004 were docetaxel for prostate cancer and pemetrexed and epidermal growth factor receptor mutations for non-small-cell lung cancer. The major advance for breast cancer was the use of aromatase inhibitors for adjuvant treatment. For colorectal cancer, the major development was the outcome of the trials studying bevacizumab and cetuximab.

UR - http://www.scopus.com/inward/record.url?scp=26944440560&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=26944440560&partnerID=8YFLogxK

U2 - 10.7326/0003-4819-143-8-200510180-00009

DO - 10.7326/0003-4819-143-8-200510180-00009

M3 - Review article

C2 - 16230725

AN - SCOPUS:26944440560

SN - 0003-4819

VL - 143

SP - 587

EP - 592

JO - Annals of internal medicine

JF - Annals of internal medicine

IS - 8

ER -

Update in oncology

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this